Growth-coupled production of L-isoleucine in Escherichia coli via metabolic engineering

L-isoleucine, an essential amino acid, is widely used in the pharmaceutical and food industries. However, the current production efficiency is insufficient to meet the increasing demands. In this study, we aimed to develop an efficient L-isoleucine-producing strain of Escherichia coli. First, accumu...

Full description

Saved in:
Bibliographic Details
Published inMetabolic engineering Vol. 86; pp. 181 - 193
Main Authors Lu, Nan, Wei, Minhua, Yang, Xuejing, Li, Yingzi, Sun, Hao, Yan, Qianyu, Zhang, Haibin, He, Jilong, Ma, Jie, Xia, Menglei, Zhang, Chenglin
Format Journal Article
LanguageEnglish
Published Belgium Elsevier Inc 01.11.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:L-isoleucine, an essential amino acid, is widely used in the pharmaceutical and food industries. However, the current production efficiency is insufficient to meet the increasing demands. In this study, we aimed to develop an efficient L-isoleucine-producing strain of Escherichia coli. First, accumulation of L-isoleucine was achieved by employing feedback-resistant enzymes. Next, a growth-coupled L-isoleucine synthetic pathway was established by introducing the metA-metB-based α-ketobutyrate-generating bypass, which significantly increased L-isoleucine production to 7.4 g/L. Upon employing an activity-improved cystathionine γ-synthase mutant obtained from adaptive laboratory evolution, L-isoleucine production further increased to 8.5 g/L. Subsequently, the redox flux was improved by bypassing the NADPH-dependent aspartate aminotransferase pathway and employing the NADH-dependent pathway and transhydrogenase. Finally, L-isoleucine efflux was enhanced by modifying the transport system. After fed-batch fermentation for 48 h, the resultant strain, ISO-12, reached an L-isoleucine production titer of 51.5 g/L and yield of 0.29 g/g glucose. The strains developed in this study achieved a higher L-isoleucine production efficiency than those reported previously. These strategies will aid in the development of cell factories that produce L-isoleucine and related products. [Display omitted] •Growth-coupled production of L-isoleucine was achieved in Escherichia coli.•Feedback regulation of key enzymes in L-isoleucine synthesis was abrogated.•A growth-coupled L-isoleucine synthetic pathway was established.•The redox flux was improved via NADH dependent pathways and transhydrogenase.•High production titer and yield of L-isoleucine was fulfilled.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1096-7176
1096-7184
1096-7184
DOI:10.1016/j.ymben.2024.10.004